XGN
Exagen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$7.58
+0.53%Margins
Gross margin
58.6%
EBITDA margin
-16.1%
EBIT margin
-18.6%
Net margin
-26.6%
FCF margin
-10.7%
-154.9%
Return on equity
-36.4%
Return on assets
-35.0%
Return on invested capital
1.37x
Asset turnover
-$6.5M
Cash from operations
$1.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026